Annual Operating Profit
-$25.65 M
+$8.45 M+24.77%
December 31, 2023
Summary
- As of February 7, 2025, PBLA annual operating income is -$25.65 million, with the most recent change of +$8.45 million (+24.77%) on December 31, 2023.
- During the last 3 years, PBLA annual operating profit has fallen by -$19.89 million (-345.72%).
- PBLA annual operating profit is now -9168.95% below its all-time high of $282.80 thousand, reached on December 31, 2012.
Performance
PBLA Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Profit
-$7.17 M
+$938.00 K+11.58%
September 30, 2024
Summary
- As of February 7, 2025, PBLA quarterly operating income is -$7.17 million, with the most recent change of +$938.00 thousand (+11.58%) on September 30, 2024.
- Over the past year, PBLA quarterly operating profit has dropped by -$121.00 thousand (-1.72%).
- PBLA quarterly operating profit is now -5836.59% below its all-time high of $124.90 thousand, reached on December 31, 2012.
Performance
PBLA Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Operating Profit
-$29.04 M
+$681.00 K+2.29%
September 30, 2024
Summary
- As of February 7, 2025, PBLA TTM operating income is -$29.04 million, with the most recent change of +$681.00 thousand (+2.29%) on September 30, 2024.
- Over the past year, PBLA TTM operating profit has dropped by -$3.41 million (-13.31%).
- PBLA TTM operating profit is now -10371.67% below its all-time high of $282.70 thousand, reached on December 31, 2012.
Performance
PBLA TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Profit Formula
Operating Profit = Gross Profit − Operating Expenses
PBLA Operating Profit Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +24.8% | -1.7% | -13.3% |
| 3 y3 years | -345.7% | -47.4% | +16.9% |
| 5 y5 years | -568.4% | -47.4% | +16.9% |
PBLA Operating Profit Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -156.2% | +24.8% | -116.4% | +66.3% | -190.5% | +16.9% |
| 5 y | 5-year | -493.4% | +24.8% | -572.1% | +66.3% | -571.9% | +16.9% |
| alltime | all time | -9169.0% | +24.8% | -5836.6% | +66.3% | <-9999.0% | +16.9% |
Panbela Therapeutics Operating Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$7.17 M(-11.6%) | -$29.04 M(-2.3%) |
| Jun 2024 | - | -$8.10 M(+20.5%) | -$29.72 M(+8.1%) |
| Mar 2024 | - | -$6.73 M(-4.5%) | -$27.49 M(+7.3%) |
| Dec 2023 | -$25.65 M(-24.8%) | -$7.04 M(-10.2%) | -$25.63 M(+7.8%) |
| Sep 2023 | - | -$7.85 M(+33.5%) | -$23.76 M(+21.6%) |
| Jun 2023 | - | -$5.88 M(+20.9%) | -$19.54 M(-44.1%) |
| Mar 2023 | - | -$4.86 M(-6.2%) | -$34.95 M(+2.5%) |
| Dec 2022 | -$34.09 M(+240.6%) | -$5.18 M(+43.0%) | -$34.09 M(+5.8%) |
| Sep 2022 | - | -$3.62 M(-83.0%) | -$32.22 M(+4.6%) |
| Jun 2022 | - | -$21.29 M(+431.6%) | -$30.81 M(+162.2%) |
| Mar 2022 | - | -$4.00 M(+20.9%) | -$11.75 M(+17.6%) |
| Dec 2021 | -$10.01 M(+74.0%) | -$3.31 M(+49.8%) | -$9.99 M(+20.6%) |
| Sep 2021 | - | -$2.21 M(-0.7%) | -$8.29 M(+2.7%) |
| Jun 2021 | - | -$2.23 M(-1.0%) | -$8.07 M(+16.1%) |
| Mar 2021 | - | -$2.25 M(+40.4%) | -$6.95 M(+20.5%) |
| Dec 2020 | -$5.75 M(+33.1%) | -$1.60 M(-19.8%) | -$5.77 M(+6.7%) |
| Sep 2020 | - | -$2.00 M(+80.8%) | -$5.41 M(+13.8%) |
| Jun 2020 | - | -$1.10 M(+3.6%) | -$4.75 M(+0.3%) |
| Mar 2020 | - | -$1.07 M(-14.0%) | -$4.74 M(+9.6%) |
| Dec 2019 | -$4.32 M(+12.6%) | -$1.24 M(-7.7%) | -$4.32 M(+16.3%) |
| Sep 2019 | - | -$1.34 M(+23.3%) | -$3.72 M(+13.9%) |
| Jun 2019 | - | -$1.09 M(+66.6%) | -$3.26 M(+0.1%) |
| Mar 2019 | - | -$653.00 K(+3.0%) | -$3.26 M(-15.0%) |
| Dec 2018 | -$3.84 M | -$634.00 K(-28.6%) | -$3.83 M(-22.6%) |
| Sep 2018 | - | -$888.00 K(-18.1%) | -$4.96 M(-2.6%) |
| Jun 2018 | - | -$1.08 M(-11.7%) | -$5.09 M(+0.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2018 | - | -$1.23 M(-30.1%) | -$5.08 M(-13.1%) |
| Dec 2017 | -$5.85 M(+13.3%) | -$1.76 M(+72.5%) | -$5.85 M(-5.7%) |
| Sep 2017 | - | -$1.02 M(-5.7%) | -$6.20 M(-1.9%) |
| Jun 2017 | - | -$1.08 M(-45.9%) | -$6.32 M(+2.1%) |
| Mar 2017 | - | -$1.99 M(-5.6%) | -$6.19 M(+19.7%) |
| Dec 2016 | -$5.17 M(-5.1%) | -$2.11 M(+86.1%) | -$5.17 M(+19.1%) |
| Sep 2016 | - | -$1.14 M(+19.6%) | -$4.34 M(+9.2%) |
| Jun 2016 | - | -$949.00 K(-2.7%) | -$3.98 M(-5.8%) |
| Mar 2016 | - | -$975.00 K(-24.1%) | -$4.22 M(-22.2%) |
| Dec 2015 | -$5.44 M(+58.0%) | -$1.28 M(+66.8%) | -$5.43 M(+7.3%) |
| Sep 2015 | - | -$770.00 K(-35.5%) | -$5.06 M(-6.4%) |
| Jun 2015 | - | -$1.19 M(-45.4%) | -$5.41 M(+26.8%) |
| Mar 2015 | - | -$2.18 M(+138.6%) | -$4.26 M(+95.3%) |
| Dec 2014 | -$3.44 M(+1673.0%) | -$915.00 K(-17.9%) | -$2.18 M(+70.2%) |
| Sep 2014 | - | -$1.11 M(+2132.5%) | -$1.28 M(+476.5%) |
| Jun 2014 | - | -$49.90 K(-51.8%) | -$222.40 K(+3.0%) |
| Mar 2014 | - | -$103.50 K(+604.1%) | -$216.00 K(+14.7%) |
| Dec 2013 | -$194.30 K(-168.7%) | -$14.70 K(-72.9%) | -$188.30 K(+286.7%) |
| Sep 2013 | - | -$54.30 K(+24.8%) | -$48.70 K(-155.2%) |
| Jun 2013 | - | -$43.50 K(-42.6%) | $88.30 K(-62.1%) |
| Mar 2013 | - | -$75.80 K(-160.7%) | $233.00 K(-17.6%) |
| Dec 2012 | $282.80 K(-370.6%) | $124.90 K(+51.0%) | $282.70 K(+79.2%) |
| Sep 2012 | - | $82.70 K(-18.3%) | $157.80 K(+110.1%) |
| Jun 2012 | - | $101.20 K(-487.7%) | $75.10 K(-387.7%) |
| Mar 2012 | - | -$26.10 K | -$26.10 K |
| Dec 2011 | -$104.50 K | - | - |
FAQ
- What is Panbela Therapeutics annual operating income?
- What is the all time high annual operating profit for Panbela Therapeutics?
- What is Panbela Therapeutics annual operating profit year-on-year change?
- What is Panbela Therapeutics quarterly operating income?
- What is the all time high quarterly operating profit for Panbela Therapeutics?
- What is Panbela Therapeutics quarterly operating profit year-on-year change?
- What is Panbela Therapeutics TTM operating income?
- What is the all time high TTM operating profit for Panbela Therapeutics?
- What is Panbela Therapeutics TTM operating profit year-on-year change?
What is Panbela Therapeutics annual operating income?
The current annual operating profit of PBLA is -$25.65 M
What is the all time high annual operating profit for Panbela Therapeutics?
Panbela Therapeutics all-time high annual operating income is $282.80 K
What is Panbela Therapeutics annual operating profit year-on-year change?
Over the past year, PBLA annual operating income has changed by +$8.45 M (+24.77%)
What is Panbela Therapeutics quarterly operating income?
The current quarterly operating profit of PBLA is -$7.17 M
What is the all time high quarterly operating profit for Panbela Therapeutics?
Panbela Therapeutics all-time high quarterly operating income is $124.90 K
What is Panbela Therapeutics quarterly operating profit year-on-year change?
Over the past year, PBLA quarterly operating income has changed by -$121.00 K (-1.72%)
What is Panbela Therapeutics TTM operating income?
The current TTM operating profit of PBLA is -$29.04 M
What is the all time high TTM operating profit for Panbela Therapeutics?
Panbela Therapeutics all-time high TTM operating income is $282.70 K
What is Panbela Therapeutics TTM operating profit year-on-year change?
Over the past year, PBLA TTM operating income has changed by -$3.41 M (-13.31%)